CZT Cozart

RNS Number:0309B
Cozart PLC
30 July 2007

                                   Cozart plc

   Home Office Expands Drugs Intervention Programme using Cozart Products and
                                    Services

          - HO commences roll out of National Drug Testing Standards -

Abingdon, Oxfordshire, 30 July 2007 - Cozart plc ('Cozart' or the 'Company'),
the medical diagnostics company, notes the Home Office's release of guidelines
allowing police forces in England and Wales to expand and extend the Drug
Interventions Programme ("DIP") using the Cozart RapiScan system.

The expansion is possible following the release by the Home Office of "Guidance
for Partnership Areas" applying for intensive Drug Interventions Programme
status, a key component of which is drug testing in custody suites. This will
enable police forces who are not currently involved in the programme to sign up
providing they meet the various requirements set by the DIP including the
ability to fund testing locally.

The DIP uses the Cozart RapiScan point-of-contact oral fluid drug testing system
to test the saliva of arrestees, in just 3 minutes, for the presence of cocaine,
crack cocaine and heroin in the police custody suite.  Currently 173 police
custody suites across England and Wales perform this type of testing (there are
over 600 custody suites in England and Wales).

Home Office figures illustrate that the DIP is successful in helping reduce
drug-related crime in England and Wales.  Since it began, acquisitive crime - to
which drug-related crime makes a substantial contribution - has fallen by a
fifth.

The Guidance is also expected to encourage police forces already involved in the
DIP, but not testing force-wide, to expand their current testing across the
police area.

Cozart recently announced the award of an additional contract to perform
supplementary laboratory testing by GC/MS (gas chromatography with mass
spectrometry) in support of the point-of-contact testing.  This laboratory
testing service will also expand as new sites begin the DIP on-site testing
process.

Dr Chris Hand, Cozart Chief Executive said, "This roll out of the DIP scheme is
a significant endorsement of the success of the programme of which saliva drug
testing in custody, using the Cozart RapiScan system, is an integral part.
Cozart are aware of many police areas which have expressed an interest in
joining the DIP: this includes police forces that currently perform testing who
intend to roll out force wide and forces which intend to begin this type of
testing for the first time.  We expect the first of these extensions to begin
within the next few weeks.  With testing currently in 173 of the total of more
than 600 sites across England & Wales there is significant potential for
expansion."

Enquiries:

Cozart plc:
Tel: 01235 861 483
Dr Chris Hand, Chief Executive
Chris Yates, Finance Director
www.cozartgroup.com

Financial Dynamics:
Tel:  020 7269 7242
Ben Atwell
Anna Keeble


Notes to Editors - Cozart plc

Cozart is a medical diagnostics company which develops, manufactures and sells
immunodiagnostic tests, predominantly those used for the detection of drugs of
abuse. Cozart's products include laboratory based testing kits for the detection
of drugs in a variety of biological samples and the Cozart(R) RapiScan and
Cozart DDS systems, portable devices used for the on-site testing of drugs of
abuse in saliva (oral fluid) samples. In July 2004 Cozart floated on London's
AIM (trading symbol: CZT).  Cozart has wholly owned subsidiaries in Spain
(Spinreact SA based near Barcelona); Sweden (HL Scandinavia and Medib
Scandinavian), Italy (Cozart Italia) and UK (Nemesis Scientific Limited).

Cozart supplies point of contact testing products, laboratory services and
forensic testing kits to the criminal justice (e.g. police forces, probation
services and prisons), medical (e.g. hospitals and drug dependency clinics) and
workplace markets (e.g. pre-employment, random and 'for cause' testing) both in
the UK and internationally.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

STRILFFEDVIDFID

Cozart (LSE:CZT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Cozart (LSE:CZT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024